- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Miraculins Appoints Ashwath Mehra to Board of Directors
Miraculins Inc. (TSXV:MOM) announced it has appointed Ashwath Mehra to the company’s board of directors.
Miraculins Inc. (TSXV:MOM) announced it has appointed Ashwath Mehra to the company’s board of directors.
Mr. Mehra holds a BSc (economics) from the London School of Economics and is currently the chief executive officer of the Astor Group, an investment and advisory group of businesses. He has worked in the minerals industry for 22 years, starting his career with Philipp Brothers, after which he spent 10 years with Glencore, where he was a senior partner, and ran the nickel and cobalt divisions. Mr. Mehra has substantial experience in mineral projects and project finance.
Connect with Miraculins Inc. (TSXV:MOM) to receive an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.